Earnings
Solventum Lifts 2026 Earnings Outlook To $7.20–$7.30 As Advance Orders Reverse
The healthcare supplier completed its business-system transitions, while wound care and software sales grew and dental sales fell.
Solventum (SOLV) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
The healthcare supplier completed its business-system transitions, while wound care and software sales grew and dental sales fell.
Earnings
The CFO says a renegotiated 3M agreement removes an April 2027 cost step-up, and full-year earnings guidance rises to $7.20 to $7.30 a share.